Atlas FDA

IMMULITE & IMMULITE 2000 HBSAG ASSAY

FDA premarket approval P010050/S007 · decided 2009-02-09

Approval details

PMA number
P010050
Supplement
S007
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
IMMULITE & IMMULITE 2000 HBSAG ASSAY
Generic name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Applicant
Siemens Healthcare Diagnostics Products, Ltd.
Date received
2008-12-02
Decision date
2009-02-09
Days to decision
69 days
Decision code
APPR
Product code
LOM
Advisory committee
Microbiology
Expedited review
No
Location
Llanberis
Statement
APPROVAL FOR REPLACEMENT OF THE SODIUM BASED BUFFER WITH POTASSIUM PHOSPHATEBUFFER AND ADDITION OF 2.0% NORMAL MOUSE SERUM AND 1.2% E-AMINO-N-CAPROIC ACID IN REAGENT A,AND THE ADDITION OF 0.2% SODIUM HEPARIN IN REAGENT B FOLLOWED BY REFILTERING OF DILUENT, AND ISINDICATED FOR IN VITRO DIAGNOSTIC USE FOR THE LABORATORY DIAGNOSIS OF ACUTE AND CHRONIC HEPATITIS BVIRUS INFECTIONS IN CONJUNCTION WITH OTHER SEROLOGICAL AND CLINICAL INFORMATION.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
IMMULITE® 2000 BR-MA (K233946)Siemens Healthcare Diagnostics Products, Ltd.2024-03-13
IMMULITE/IMMULITE 1000 OM-MA, IMMULITE 2000 OM-MA (K213510)Siemens Healthcare Diagnostics Products, Ltd.2023-09-08
IMMULITE® 2000 Cortisol (K202826)Siemens Healthcare Diagnostics Products, Ltd.2021-01-15
IMMULITE/IMMULITE® 1000 Cortisol (K203270)Siemens Healthcare Diagnostics Products, Ltd.2021-01-15